Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study

IntroductionSafety of biosimilars is of major relevance for patients and medical community. The aim of this study was to evaluate the safety and tolerability of a bevacizumab biosimilar alongside standard chemotherapy in adult patients with cancer. In addition, the impact on patients’ quality-of-lif...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Alberto Alfonso Pimentel-Rentería, David Francisco Cantú de León, Eliseo Neftalí De la Cruz, David Suárez, Manuel Rodulfo Segura, José Gustavo Núñez, Livan Delgado-Roche
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2025-05-01
Цуврал:	Frontiers in Drug Discovery
Нөхцлүүд:	bevacizumab biosimilar metastatic cancer safety pharmacovigilance
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fddsv.2025.1591991/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!